P&K Skin Research Center Co.,Ltd. Logo

P&K Skin Research Center Co.,Ltd.

Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.

347740 | KO

Overview

Corporate Details

ISIN(s):
KR7347740003
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 국회대로62길 25 교육시설재난공제회관 4층, 영등포구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

P&K Skin Research Center Co., Ltd. is a clinical research organization specializing in dermatological testing and evaluation. The company provides a comprehensive suite of services for the cosmetics, pharmaceutical, and health functional food sectors. Its offerings include human application trials, safety and efficacy testing, in vitro analysis, and sensory evaluation. In addition to its core research services, P&K also develops, manufactures, and sells functional raw materials. The company focuses on providing scientific and systematic technical support, utilizing advanced testing methods to substantiate product claims.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.7 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.5 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 359.0 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.0 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 210.7 KB
2025-02-28 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.8 KB
2025-02-17 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.4 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
Annual Report
분기보고서 (2024.09)
Korean 1.0 MB
2024-11-14 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 24.8 KB
2024-11-14 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 18.2 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 1.0 MB

Automate Your Workflow. Get a real-time feed of all P&K Skin Research Center Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for P&K Skin Research Center Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for P&K Skin Research Center Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea
251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America
ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan
8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland
APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea
149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America
ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy
ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America
ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan
246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.